Altered Duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet

American Journal of Gastroenterology

Volumn 109, Issue 12, 2014, Pages 1933-1941

  Wacklin, Pirjo ^a   Laurikka, Pilvi ^b   Lindfors, Katri ^b   Collin, Pekka ^b,c   Salmi, Teea ^b,c   Lähdeaho, Marja Leena ^b   Saavalainen, Païvi ^d   Mäki, Markku ^b   Mättö, Jaana ^a   Kurppa, Kalle ^b   Kaukinen, Katri ^b,c  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN; RNA 16S;

ADULT; AGED; ARTICLE; BACTEROIDETES; CELIAC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA EXTRACTION; DUODENAL MICROBIOTA COMPOSITION; FEMALE; FIRMICUTES; GASTROINTESTINAL ENDOSCOPY; GLUTEN FREE DIET; HUMAN; INTESTINE FLORA; MALE; NONHUMAN; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PROTEOBACTERIA; PYROSEQUENCING; SMALL INTESTINE MUCOSA; ACTINOBACTERIA; COHORT ANALYSIS; COMPLICATION; DIET THERAPY; DUODENUM; DYSBIOSIS; FUSOBACTERIA; GENETICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; TREATMENT FAILURE;

ACTINOBACTERIA; ADULT; AGED; BACTEROIDETES; CELIAC DISEASE; COHORT STUDIES; DIET, GLUTEN-FREE; DUODENUM; DYSBIOSIS; FEMALE; FUSOBACTERIA; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; PROTEOBACTERIA; RNA, RIBOSOMAL, 16S; TREATMENT FAILURE;

EID: 84925223549     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.355     Document Type: Article

References (54)

1. Dewar DH, Donnelly SC, McLaughlin SD et al. Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol 2012; 18: 1348-56.
2. Paarlahti P, Kurppa K, Ukkola A et al. Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large crosssectional study. BMC Gastroenterol 2013; 13: 75.
3. Leffler DA, Dennis M, Hyett B et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007; 5: 445-50.
4. Midhagen G, Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol 2003; 98: 2023-6.
5. Nadal I, Donat E, Ribes-Koninckx C et al. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007; 56: 1669-74.
6. Collado MC, Donat E, Ribes-Koninckx C et al. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009; 62: 264-9.
7. De Palma G, Nadal I, Medina M et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 2010; 10: 63.
8. Wacklin P, Kaukinen K, Tuovinen E et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 2013; 19: 934-41.
9. Nistal E, Caminero A, Herran AR et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm Bowel Dis 2012; 18: 649-56.
10. Taavela J, Koskinen O, Huhtala H et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One 2013; 8: e76163.
11. Jarvinen TT, Kaukinen K, Laurila K et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 2003; 98: 1332-7.
12. Svedlund J, Sjodin I, Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-34.
13. Simren M, Axelsson J, Gillberg R et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97: 389-96.
14. Paavola A, Kurppa K, Ukkola A et al. Gastrointestinal symptoms and quality of life in screen-detected celiac disease. Dig Liver Dis 2012; 44: 814-8.
15. Peraaho M, Kaukinen K, Paasikivi K et al. Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 2003; 17: 587-94.
16. Viljamaa M, Collin P, Huhtala H et al. Is coeliac disease screening in risk groups justifi ed? A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther 2005; 22: 317-24.
17. Sulkanen S, Collin P, Laurila K et al. IgA-and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998; 33: 251-4.
18. Schloss PD, Westcott SL, Ryabin T et al. Introducing mothur: open-source, platform-independent, community-supported soft ware for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75: 7537-41.
19. Pruesse E, Quast C, Knittel K et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 2007; 35: 7188-96.
20. R Development Core Team. R: A Language and Environment for Statistical Computing 2012; www.r-project.org/.
21. Oksanen J, Blanchet G, Kindt R et al. Vegan: Community ecology package. R Package 2012; 2: 0-3.
22. Rossi J. Rich: Species richness estimation and comparison. R Package 2011; 0: 1.
23. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005; 71: 8228-35.
24. Malinen E, Rinttila T, Kajander K et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-82.
25. Mt J, Maunuksela L, Kajander K et al. Composition and temporal stabi lity of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213-22.
26. Macfarlane GT, Blackett KL, Nakayama T et al. The gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15: 1528-36.
27. Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010; 59: 547-57.
28. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011; 108 ( Suppl 1 ): 4554-61.
29. Lozupone CA, Stombaugh JI, Gordon JI et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-30.
30. Willing BP, Dicksved J, Halfvarson J et al. A pyrosequencing study in twins shows that gastrointestinal microbial profi les vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-1854e1.
31. Frank DN St, Amand AL, Feldman RA et al. Molecular-phylogenetic charac terization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-5.
32. Mukhopadhya I, Hansen R, El-Omar EM et al. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9: 219-30.
33. Wang M, Ahrne S, Jeppsson B et al. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 2005; 54: 219-31.
34. Booijink CC, Zoetendal EG, Kleerebezem M et al. Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol 2007; 2: 285-95.
35. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779-82.
36. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterol 2009; 136: 1979-88.
37. Jacobs JP, Braun J. Immune and genetic gardening of the intestinal microbiome. FEBS Lett 2014; doi: 10.1016/j.febslet.2014.02.052 (e-pub ahead of print).
38. Wacklin P, M?ivuokko H, Alakulppi N et al. Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifi dobacteria in the human intestine. PLoS One 2011; 6: e20113.
39. Parmar AS, Alakulppi N, Paavola-Sakki P et al. Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population. Tissue Antigens 2012; 80: 488-93.
40. Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003; 98: 839-43.
41. Rubio-Tapia A, Barton SH, Rosenblatt JE et al. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 2009; 43: 157-61.
42. Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis 2013; 4: 223-31.
43. Bures J, Cyrany J, Kohoutova D et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-90.
44. Bouhnik Y, Alain S, Attar A et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94: 1327-31.
45. Grace E, Shaw C, Whelan K et al. Review article: small intestinal bacterial overgrowth-prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013; 38: 674-88.
46. Booijink CC, El-Aidy S, Rajilic-Stojanovic M et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol 2010; 12: 3213-27.
47. den Hollander WJ, Sostres C, Kuipers EJ et al. Helicobacter pylori and nonmalignant diseases. Helicobacter 2013; 18: 24-7.
48. Mueller S, Saunier K, Hanisch C et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006; 72: 1027-33.
49. Mariat D, Firmesse O, Levenez F et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009; 9: 123.
50. Biagi E, Nylund L, Candela M et al. Th rough ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010; 5: e10667.
51. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
52. Sanders ME, Guarner F, Guerrant R et al. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787-96.
53. Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-98.
54. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15: 337.